Trial intelligence / Profile preview

Nifedipine GITS and telmisartan combination versus stepwise monotherapy strategy in hypertension

2006-006436-22Phase 4Completed

Sponsor
Bayer
Start
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of nifedipine and telmisartan in hypertension (HTN) (2 arms), sponsored by Bayer. Primary endpoint: Efficacy in blood pressure control. Started Jun 2007; status: completed.

02

Drugs

nifedipinetelmisartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on 2006-006436-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006436-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call